Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

December 17, 2020

Transradial Access Still Beats Transfemoral for STEMI in Updated Meta-analysis

News Daily News

Transradial Access Still Beats Transfemoral for STEMI in Updated Meta-analysis

November 25, 2020

Nationwide Data Shed Light on Timing, Predictors of Acute MI in Pregnancy

News Daily News

Nationwide Data Shed Light on Timing, Predictors of Acute MI in Pregnancy

November 03, 2020

November 2020 News Roundup

News Opinion CV Team Dispatch

November 2020 News Roundup

November 01, 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

News Conference News TCT 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

October 14, 2020

Study Affirms Thrombotic Risk in COVID-19

News Daily News

Study Affirms Thrombotic Risk in COVID-19

October 01, 2020

Acute MI Patients With Anemia May Require Fewer RBC Transfusions: REALITY

News Conference News ESC 2020

Acute MI Patients With Anemia May Require Fewer RBC Transfusions: REALITY

September 01, 2020

Reduced-Dose Prasugrel Works Well in Older, Low-Weight ACS Patients

News Daily News

Reduced-Dose Prasugrel Works Well in Older, Low-Weight ACS Patients

July 21, 2020

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

News Daily News

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Michael O'Riordan

May 04, 2020

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

February 28, 2020

Outcome Differences Between Men and Women With PAD: EUCLID Insights

News Daily News

Outcome Differences Between Men and Women With PAD: EUCLID Insights

February 11, 2020

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.